Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017186889) PROTEIN BASED EXCIPIENT FOR ACTIVE PHARMACEUTICAL INGREDIENTS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/186889 International Application No.: PCT/EP2017/060143
Publication Date: 02.11.2017 International Filing Date: 28.04.2017
Chapter 2 Demand Filed: 29.11.2017
IPC:
A61K 47/42 (2017.01) ,A61K 47/34 (2017.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
42
Proteins; Polypeptides; Degradation products thereof; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
34
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
Applicants:
ROUSSELOT B.V. [NL/NL]; Kanaaldijk Noord 20-21 5691 Son NM, NL
Inventors:
VERGAUWEN, Bjorn; BE
VAN DE MOOTER, Guy; BE
Agent:
PAPPAERT, Kris; BE
PAEMEN, Liesbet; BE
BOUNAGA, Sakina; BE
DE CLERCQ, Ann; BE
MICHALÍK, Andrej; BE
VANHALST, Koen; BE
GYI, Jeffrey; BE
BOGAERTS, Sven; BE
DE CLERCQ, Annelies; BE
DEBRUYNE, Delphine; BE
LESTHAEGHE, David; BE
HENNIN, Caroline; BE
GOESAERT, Hans; BE
VIAENE, Ann; BE
Priority Data:
2016/530229.04.2016BE
2016/597726.12.2016BE
Title (EN) PROTEIN BASED EXCIPIENT FOR ACTIVE PHARMACEUTICAL INGREDIENTS
(FR) EXCIPIENT À BASE DE PROTÉINES DESTINÉ À DES PRINCIPES ACTIFS PHARMACEUTIQUES
Abstract:
(EN) Provided herein is a pharmaceutical formulation comprising a protein based excipient in combination with an active pharmaceutical ingredient (API) wherein said formulation is substantially amorphous and form a substantially homogenous mixture; and further a method for producing said pharmaceutical formulation; and said pharmaceutical formulation for use as a medicament.
(FR) L'invention concerne une formulation pharmaceutique comprenant un excipient à base de protéines en association avec un principe actif pharmaceutique (API), ladite formulation étant sensiblement amorphe et formant un mélange sensiblement homogène ; l'invention concerne en outre un procédé de production de ladite formulation pharmaceutique ; et ladite formulation pharmaceutique destinée à être utilisée comme médicament.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)